La médecine personnalisée est prometteuse pour les cancers récurrents et les superbactéries, mais elle demande beaucoup de travail et d’argent. Les approbations réglementaires demeurent compliquées.
- Master's student in the Biomedical Discovery and Commercialization program, McMaster University
Personalized medicine is a promising treatment for recurrent cancer and superbugs, but it is labour-intensive and expensive, and pathways for its regulatory approval and reimbursement are complicated.
Contact Elizabeth for
- General
- Media request
- Research collaboration
- Research supervision
- Article Feed
- Joined
